Literature DB >> 26632506

Direct and indirect costs and resource use in dementia care: A cross-sectional study in patients living at home.

Marta Farré1, Josep Maria Haro2, Belchin Kostov3, Carme Alvira4, Ester Risco5, Susana Miguel6, Ester Cabrera7, Adelaida Zabalegui8.   

Abstract

BACKGROUND: Due to the high prevalence of dementia, health care needs are increasing beyond existing formal resources. In Spain, it is the family that takes care of this disease. AIMS: To analyze the direct (health and non-health) and indirect economic costs related to care of people with dementia living with their informal caregiver in the home care/community environment, from the perspective of illness severity, associated comorbidity and social impact.
DESIGN: Multicentric, descriptive study.
SETTING: Three primary care public health centers associated with Hospital Clínic, Barcelona (Spain). PARTICIPANTS: Patients over 65 years old with a diagnosis of dementia, and included in a home care program. INCLUSION CRITERIA: People with a diagnosis of dementia made by a specialist neurologist; aged 65 years or older; a score ≤ 24 on the Mini-Mental State Examination, and identification of an informal caregiver. EXCLUSION CRITERIA: Patients unable to identify an informal caregiver, and those with primary psychiatric pathology or Korsakoff's syndrome. MEASUREMENTS: Use of Resources in Dementia to assess costs; Mini-Mental State Examination to evaluate cognitive capacity; Katz-Index to measure functional capacity; Neuropsychiatric Index for neuropsychiatric symptoms, and the Charlson-Index for comorbidity. Data collection took place between November, 2010 and April, 2012.
RESULTS: The average estimated monthly care costs for people with dementia in the home setting are 1956.2€ (SD 1463.9). Informal care was the major contributor to this with a mean estimated cost of 1214.86 (SD 902.68)€/month. Greater illness severity, dependency in activities of daily living, comorbidity and behavioral disturbance are associated with higher costs. Behavioral disturbance appeared as the only factor independently associated with cost in dementia care. The group of people with dementia with severe behavioral disturbance requires the most care resources with an average cost of 2545.2 (SD 1753.2)€/month.
CONCLUSIONS: There is a direct association between dementia severity and increased costs. In addition, informal caregivers looking after people with dementia in Spain represent an important social cost. The independent factor associated with an increase in the total costs of patient care was neuropsychiatric symptoms.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Community care; Dementia; Direct cost; Formal care; Home care; Indirect cost; Informal care

Mesh:

Year:  2015        PMID: 26632506     DOI: 10.1016/j.ijnurstu.2015.10.012

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  12 in total

1.  Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey.

Authors:  Takayo Nakabe; Noriko Sasaki; Hironori Uematsu; Susumu Kunisawa; Anders Wimo; Yuichi Imanaka
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

2.  Economic costs of dementia in 11 countries in Europe: Estimates from nationally representative cohorts of a panel study.

Authors:  Erik Meijer; Maria Casanova; Hyewon Kim; Ana Llena-Nozal; Jinkook Lee
Journal:  Lancet Reg Health Eur       Date:  2022-06-24

3.  International depiction of the cost of functional independence limitations among older adults living in the community: a systematic review and cost-of-impairment study.

Authors:  Ryan S Falck; Alexis G Percival; Daria Tai; Jennifer C Davis
Journal:  BMC Geriatr       Date:  2022-10-22       Impact factor: 4.070

4.  Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease.

Authors:  Joosep Kalamägi; Piia Lavikainen; Heidi Taipale; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  Ann Med       Date:  2019-08-12       Impact factor: 5.348

5.  Vitamin B-Can it prevent cognitive decline? A systematic review and meta-analysis.

Authors:  Annika Behrens; Elmar Graessel; Anna Pendergrass; Carolin Donath
Journal:  Syst Rev       Date:  2020-05-15

Review 6.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Authors:  Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Predictor Factors of Perceived Health in Family Caregivers of People Diagnosed with Mild or Moderate Alzheimer's Disease.

Authors:  María Dolores Ruiz-Fernández; José Manuel Hernández-Padilla; Rocío Ortiz-Amo; Cayetano Fernández-Sola; Isabel María Fernández-Medina; José Granero-Molina
Journal:  Int J Environ Res Public Health       Date:  2019-10-07       Impact factor: 3.390

8.  The social and economic burden of frontotemporal degeneration.

Authors:  James E Galvin; David H Howard; Sharon S Denny; Susan Dickinson; Nadine Tatton
Journal:  Neurology       Date:  2017-10-04       Impact factor: 9.910

9.  For better or worse: Factors predicting outcomes of family care of older people over a one-year period. A six-country European study.

Authors:  Daniel Lüdecke; Barbara Bien; Kevin McKee; Barbro Krevers; Elizabeth Mestheneos; Mirko Di Rosa; Olaf von dem Knesebeck; Christopher Kofahl
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

10.  Care of older people with Cognitive Impairment or Dementia Hospitalized in Traumatology Units (CARExDEM): a quasi-experiment.

Authors:  Claudia Casafont; Ester Risco; Mercè Piazuelo; Marta Ancín-Pagoto; José Luis Cobo-Sánchez; Montserrat Solís-Muñoz; Adelaida Zabalegui
Journal:  BMC Geriatr       Date:  2020-07-16       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.